NPC
ARNA

National Planning Corporation’s Arena Pharmaceuticals Inc ARNA Stock Holding History

National Planning Corporation’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,545
Closed -$22K – 789
2017
Q1 		$22K Hold
1,545
– – ﹤0.01% 703
2016
Q4 		$25K Sell
1,545
-200
-11% -$3.1K ﹤0.01% 688
2016
Q3 		$26K Sell
1,745
-355
-17% -$5.89K ﹤0.01% 649
2016
Q2 		$34K Sell
2,100
-63
-3% -$1.13K ﹤0.01% 657
2016
Q1 		$34K Sell
2,163
-227
-9% -$3.64K ﹤0.01% 633
2015
Q4 		$38K Sell
2,390
-1,570
-40% -$32K ﹤0.01% 716
2015
Q3 		$87K Sell
3,960
-2,050
-34% -$69.6K 0.01% 604
2015
Q2 		$203K Sell
6,010
-300
-5% -$13K 0.02% 579
2015
Q1 		$266K Buy
6,310
+140
+2% +$6.51K 0.02% 519
2014
Q4 		$361K Sell
6,170
-1,175
-16% -$47.7K 0.03% 494
2014
Q3 		$299K Sell
7,345
-95
-1% -$4.24K 0.02% 558
2014
Q2 		$436K Sell
7,440
-25
-0.3% -$1.57K 0.03% 446
2014
Q1 		$498K Buy
7,465
+865
+13% +$57.4K 0.04% 377
2013
Q4 		$392K Buy
6,600
+695
+12% +$36.3K 0.03% 441
2013
Q3 		$305K Buy
5,905
+295
+5% +$19.8K 0.03% 486
2013
Q2 		$436K Buy
+5,610
New +$458K 0.05% 309

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

National Planning Corporation's ARNA Position: Q2 2017 in Review

National Planning Corporation sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2017, closing a stake of 1,545 shares — an estimated $22K sold.

National Planning Corporation first reported a position in ARNA in Q2 2013 and held it in 16 quarters. The position peaked at $498K in Q1 2014. 102 funds tracked by Wall St. Rank hold ARNA as of Q2 2017.

  • National Planning Corporation reported no remaining Arena Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • National Planning Corporation sold 1,545 Arena Pharmaceuticals Inc shares in Q2 2017, an estimated $22K.
  • National Planning Corporation first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 16 quarters.
  • National Planning Corporation's Arena Pharmaceuticals Inc position peaked at $498K in Q1 2014.
  • 102 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2017.

Based on National Planning Corporation's 13F filing for Q2 2017, filed 2 Aug 2017.